Come up with a name for your new list and we'll add to it:
GeneAssess raised a round of funding on June 18, 2012. Investors include
Foundation Venture Capital Group.
GeneAssess is a biotechnology company developing FRY, a predictive biomarker for breast and other cancers to detect genetic mutations in at-risk populations.…